• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PROCEPT BIOROBOTICS CORPORATION AQUABEAM ROBOTIC SYSTEM; FLUID JET REMOVAL SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PROCEPT BIOROBOTICS CORPORATION AQUABEAM ROBOTIC SYSTEM; FLUID JET REMOVAL SYSTEM Back to Search Results
Model Number AB2000
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 01/16/2020
Event Type  Injury  
Manufacturer Narrative
A review of the system's log file was conducted, which confirmed that there were no malfunctions observed during the procedure.No system malfunctions were observed.A review of the device history record (dhr) for the aquabeam system, lot number 19c00725, was conducted, which confirmed that there were no nonconformances generated during the manufacturing process of this system, which could relate to the reported event.The review indicated that the system met all required specifications when released for distribution.A review for similar events was conducted on the aquabeam system, lot number 19c00725, which confirmed that there were no other similar events reported on this system.The aquabeam system's instructions for use (ifu), ifu320301, rev.D, was reviewed and bleeding is listed as a potential perioperative risk of the aquablation procedure.The system was not returned for investigation of this complaint.Bledding is a potential risk of the aquablation procedure.Based on the review of the log file, dhr, and ifu, the event is considered not to be device related.
 
Event Description
A male patient with a clinical history of being on anticoagulant medication (eliquis) underwent an aquablation procedure (per manufacturer's instructions for use, anti-coagulant use is contra-indicated); the medication was stopped two (2) days prior to the procedure.Per standard post-aquablation procedure, cauterization of the bladder neck followed by a foley balloon catheter insertion (one of the methods recommended by the manufacturer's instructions for use to achieve hemostasis) was performed.Later in the post-anesthesia care unit (pacu) the patient was administered tranexamic acid to treat the bleeding, however; it did not help stop the bleeding (per manufacturer's instructions for use, bleeding is a potential perioperative risk of the aquablation procedure).The patient was subsequently taken back to the operating room and cauterization was performed to stop the bleeding.The patient was reported to be in good condition post-cauterization and discharged from the hospital the following day.No malfunction of the aquabeam robotic system was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AQUABEAM ROBOTIC SYSTEM
Type of Device
FLUID JET REMOVAL SYSTEM
Manufacturer (Section D)
PROCEPT BIOROBOTICS CORPORATION
900 island drive
suite 101
redwood city, ca
Manufacturer (Section G)
PROCEPT BIOROBOTICS CORPORATION
900 island drive
suite 101
redwood city, ca
Manufacturer Contact
doria esquivel
900 island drive
suite 170
redwood city, ca 
2327291
MDR Report Key9729838
MDR Text Key188339828
Report Number3012977056-2020-00008
Device Sequence Number1
Product Code PZP
UDI-Device IdentifierB614AB20001
UDI-PublicB614AB20001
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
DEN170024
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 02/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberAB2000
Device Catalogue NumberAB2000
Device Lot Number19C00725
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/20/2020
Initial Date FDA Received02/19/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/19/2019
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-